tirzepatide blindness risk and Cancer in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis You've seen the headlines. Should

The most effective strategy combines evidence-based supplementation, a fiber-rich diet, adequate protein intake, regular exercise, and long-term lifestyle habits that support metabolic health

Gregory, Ph.D

A new monoclonal antibody called bimagrumab showed 11% body weight reduction on its own, while simultaneously increasing lean mass by 3% without affecting appetite

Patients with a history of allergic reactions or sensitivities to GLP-1 receptor agonists, pancreatitis, thyroid cancerincluding medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN-2) generally are not suitable candidates for this therapy